Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-03-01 @ 9:59 AM
Study NCT ID:
NCT05400603
Status:
RECRUITING
Last Update Posted:
2025-09-15
First Post:
2022-05-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
Sponsor:
Emory University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY00003123
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None